CyTOF reveals platelet subtype changes predicting the efficacy of combined immunotherapy and targeted therapy in liver cancer

CyTOF reveals platelet subtype changes predicting the efficacy of combined immunotherapy and targeted therapy in liver cancer

IntroductionImmune checkpoint inhibitors combined with angiogenesis inhibitors are currently the first-line treatment for liver cancer. However, some patients still exhibit poor therapeutic outcomes. Platelets, as a critical component of blood, play a significant role in liver cancer progression by...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenjing Wang, Dan Liu, Lilin Wang, Maimaitijiang Wubuli Aishan, Li Chen, Sujun Zheng, Junfeng Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Immunology
Subjects:
liver cancer
platelets
CyTOF
combined immunotherapy and targeted therapy
CD29+
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1538652/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items